Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 14581

1.

Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.

Jhund PS, Fu M, Bayram E, Chen CH, Negrusz-Kawecka M, Rosenthal A, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Eur Heart J. 2015 Jul 31. pii: ehv330. [Epub ahead of print]

PMID:
26231885
2.

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.

Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth HJ, Opitz C, Ulrich S, Egenlauf B, Grünig E.

Eur Heart J. 2015 Jul 31. pii: ehv337. [Epub ahead of print]

PMID:
26231884
3.
4.
5.

Sir Donald Ross, pioneer aortic valve surgeon.

Wheatley D.

Eur Heart J. 2015 Jun 1;36(21):1280.

PMID:
26229999
6.

Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers.

Healy GN, Winkler EA, Owen N, Anuradha S, Dunstan DW.

Eur Heart J. 2015 Jul 30. pii: ehv308. [Epub ahead of print]

PMID:
26228867
7.

Standing for healthier lives-literally.

Lopez-Jimenez F.

Eur Heart J. 2015 Jul 30. pii: ehv356. [Epub ahead of print] No abstract available.

PMID:
26228866
8.

Research ethics needs fine tuning, not rigidity: how to promote evidence in neglected patient populations by rethinking informed consent.

Jukema JW, Brouwer JR, Lüscher TF, Engberts DP, Quax PH.

Eur Heart J. 2015 Jul 28. pii: ehv358. [Epub ahead of print] Review. No abstract available.

PMID:
26224079
9.

Adolfo J de Bold PhD OC FRSC.

[No authors listed]

Eur Heart J. 2015 Jul 28. pii: ehv354. [Epub ahead of print] No abstract available.

PMID:
26224078
10.

Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Authors/Task Force Members.

Eur Heart J. 2015 Jul 28. pii: ehu479. [Epub ahead of print] No abstract available.

PMID:
26224077
11.

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P.

Eur Heart J. 2015 Jul 28. pii: ehv338. [Epub ahead of print]

PMID:
26224076
12.

Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase.

Virdis A, Duranti E, Colucci R, Ippolito C, Tirotta E, Lorenzini G, Bernardini N, Blandizzi C, Taddei S.

Eur Heart J. 2015 Jul 28. pii: ehv365. [Epub ahead of print]

PMID:
26224075
13.

Unusual echocardiographic image of a left circumflex coronary artery with anomalous origin from the right coronary sinus.

Bonapace S, Adamo E, Cicciò C, Chiampan A, Canali G, Valbusa F.

Eur Heart J. 2015 Jul 28. pii: ehv341. [Epub ahead of print] No abstract available.

PMID:
26224074
14.

Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.

Castaño A, Bokhari S, Maurer MS.

Eur Heart J. 2015 Jul 28. pii: ehv328. [Epub ahead of print] No abstract available.

PMID:
26224073
15.

Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases.

Wahbi K, Bougouin W, Béhin A, Stojkovic T, Bécane HM, Jardel C, Berber N, Mochel F, Lombès A, Eymard B, Duboc D, Laforêt P.

Eur Heart J. 2015 Jul 29. pii: ehv307. [Epub ahead of print]

PMID:
26224072
16.

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.

Bernlochner I, Goedel A, Plischke C, Schüpke S, Haller B, Schulz C, Mayer K, Morath T, Braun S, Schunkert H, Siess W, Kastrati A, Laugwitz KL.

Eur Heart J. 2015 Jul 27. pii: ehv326. [Epub ahead of print]

PMID:
26216931
17.

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement.

Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H.

Eur Heart J. 2015 Jul 27. pii: ehv162. [Epub ahead of print] Review. No abstract available.

PMID:
26216920
18.

Prosthetic aortic valve endocarditis with pseudoaneurysm complicated by additional rupture of mitral-aortic intervalvular fibrosa.

Machernis NP, Jain R, Anigbogu M, Ammar KA, Brauer E, Khandheria BK.

Eur Heart J. 2015 Jul 22. pii: ehv331. [Epub ahead of print] No abstract available.

PMID:
26206214
19.

Danon disease: a rare cause of left ventricular hypertrophy with cardiac magnetic resonance follow-up.

Vago H, Somloi M, Toth A, Merkely B.

Eur Heart J. 2015 Jul 22. pii: ehv332. [Epub ahead of print] No abstract available.

PMID:
26206213
20.

Requiem for the 'vulnerable plaque'.

Libby P, Pasterkamp G.

Eur Heart J. 2015 Jul 22. pii: ehv349. [Epub ahead of print] Review. No abstract available.

PMID:
26206212
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk